instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What is the weight of the patient? | Obesogenic Behavior and Binge Eating Disorder in an Elderly Female with Schizophrenia.
Eating disorders, like binge eating, have a strong association with schizophrenia. Illness characteristics like disordered eating, cognition, and behavior can lead to eating disorders. Previous research highlighted the neurobiologica... | 90 kg. | Weight | CC BY-NC | 33820877 | 19,840,316 | 2021-06-30 |
What was the administration route of drug 'AMISULPRIDE'? | Obesogenic Behavior and Binge Eating Disorder in an Elderly Female with Schizophrenia.
Eating disorders, like binge eating, have a strong association with schizophrenia. Illness characteristics like disordered eating, cognition, and behavior can lead to eating disorders. Previous research highlighted the neurobiologica... | Oral | DrugAdministrationRoute | CC BY-NC | 33820877 | 19,840,316 | 2021-06-30 |
What was the administration route of drug 'RISPERIDONE'? | Obesogenic Behavior and Binge Eating Disorder in an Elderly Female with Schizophrenia.
Eating disorders, like binge eating, have a strong association with schizophrenia. Illness characteristics like disordered eating, cognition, and behavior can lead to eating disorders. Previous research highlighted the neurobiologica... | Oral | DrugAdministrationRoute | CC BY-NC | 33820877 | 19,840,316 | 2021-06-30 |
What was the outcome of reaction 'Weight increased'? | Obesogenic Behavior and Binge Eating Disorder in an Elderly Female with Schizophrenia.
Eating disorders, like binge eating, have a strong association with schizophrenia. Illness characteristics like disordered eating, cognition, and behavior can lead to eating disorders. Previous research highlighted the neurobiologica... | Recovered | ReactionOutcome | CC BY-NC | 33820877 | 19,840,316 | 2021-06-30 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Bronchiectasis'. | From the Heart to the Lung: A Case of Drug Toxicity.
BACKGROUND Amiodarone is an anti-arrthymic drug used to treat and prevent several types of dysrhythmias. This drug is known for multiple-organ toxicity. Lung toxicity occurs in about 1% to 5% of cases. A wide variety of lung manifestations have been described, from m... | AMIODARONE | DrugsGivenReaction | CC BY-NC-ND | 33820905 | 19,195,308 | 2021-04-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Interstitial lung disease'. | From the Heart to the Lung: A Case of Drug Toxicity.
BACKGROUND Amiodarone is an anti-arrthymic drug used to treat and prevent several types of dysrhythmias. This drug is known for multiple-organ toxicity. Lung toxicity occurs in about 1% to 5% of cases. A wide variety of lung manifestations have been described, from m... | AMIODARONE | DrugsGivenReaction | CC BY-NC-ND | 33820905 | 19,195,308 | 2021-04-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pleural thickening'. | From the Heart to the Lung: A Case of Drug Toxicity.
BACKGROUND Amiodarone is an anti-arrthymic drug used to treat and prevent several types of dysrhythmias. This drug is known for multiple-organ toxicity. Lung toxicity occurs in about 1% to 5% of cases. A wide variety of lung manifestations have been described, from m... | AMIODARONE | DrugsGivenReaction | CC BY-NC-ND | 33820905 | 19,195,308 | 2021-04-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pulmonary fibrosis'. | From the Heart to the Lung: A Case of Drug Toxicity.
BACKGROUND Amiodarone is an anti-arrthymic drug used to treat and prevent several types of dysrhythmias. This drug is known for multiple-organ toxicity. Lung toxicity occurs in about 1% to 5% of cases. A wide variety of lung manifestations have been described, from m... | AMIODARONE | DrugsGivenReaction | CC BY-NC-ND | 33820905 | 19,195,308 | 2021-04-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pulmonary toxicity'. | From the Heart to the Lung: A Case of Drug Toxicity.
BACKGROUND Amiodarone is an anti-arrthymic drug used to treat and prevent several types of dysrhythmias. This drug is known for multiple-organ toxicity. Lung toxicity occurs in about 1% to 5% of cases. A wide variety of lung manifestations have been described, from m... | AMIODARONE | DrugsGivenReaction | CC BY-NC-ND | 33820905 | 19,195,308 | 2021-04-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Toxicity to various agents'. | From the Heart to the Lung: A Case of Drug Toxicity.
BACKGROUND Amiodarone is an anti-arrthymic drug used to treat and prevent several types of dysrhythmias. This drug is known for multiple-organ toxicity. Lung toxicity occurs in about 1% to 5% of cases. A wide variety of lung manifestations have been described, from m... | AMIODARONE | DrugsGivenReaction | CC BY-NC-ND | 33820905 | 19,195,308 | 2021-04-06 |
What was the dosage of drug 'AMIODARONE'? | From the Heart to the Lung: A Case of Drug Toxicity.
BACKGROUND Amiodarone is an anti-arrthymic drug used to treat and prevent several types of dysrhythmias. This drug is known for multiple-organ toxicity. Lung toxicity occurs in about 1% to 5% of cases. A wide variety of lung manifestations have been described, from m... | 200 mg (milligrams). | DrugDosage | CC BY-NC-ND | 33820905 | 19,195,308 | 2021-04-06 |
What was the outcome of reaction 'Bronchiectasis'? | From the Heart to the Lung: A Case of Drug Toxicity.
BACKGROUND Amiodarone is an anti-arrthymic drug used to treat and prevent several types of dysrhythmias. This drug is known for multiple-organ toxicity. Lung toxicity occurs in about 1% to 5% of cases. A wide variety of lung manifestations have been described, from m... | Recovered | ReactionOutcome | CC BY-NC-ND | 33820905 | 19,195,308 | 2021-04-06 |
What was the outcome of reaction 'Interstitial lung disease'? | From the Heart to the Lung: A Case of Drug Toxicity.
BACKGROUND Amiodarone is an anti-arrthymic drug used to treat and prevent several types of dysrhythmias. This drug is known for multiple-organ toxicity. Lung toxicity occurs in about 1% to 5% of cases. A wide variety of lung manifestations have been described, from m... | Recovered | ReactionOutcome | CC BY-NC-ND | 33820905 | 19,195,308 | 2021-04-06 |
What was the outcome of reaction 'Pleural thickening'? | From the Heart to the Lung: A Case of Drug Toxicity.
BACKGROUND Amiodarone is an anti-arrthymic drug used to treat and prevent several types of dysrhythmias. This drug is known for multiple-organ toxicity. Lung toxicity occurs in about 1% to 5% of cases. A wide variety of lung manifestations have been described, from m... | Recovered | ReactionOutcome | CC BY-NC-ND | 33820905 | 19,195,308 | 2021-04-06 |
What was the outcome of reaction 'Pulmonary fibrosis'? | From the Heart to the Lung: A Case of Drug Toxicity.
BACKGROUND Amiodarone is an anti-arrthymic drug used to treat and prevent several types of dysrhythmias. This drug is known for multiple-organ toxicity. Lung toxicity occurs in about 1% to 5% of cases. A wide variety of lung manifestations have been described, from m... | Recovered | ReactionOutcome | CC BY-NC-ND | 33820905 | 19,195,308 | 2021-04-06 |
What was the outcome of reaction 'Pulmonary toxicity'? | From the Heart to the Lung: A Case of Drug Toxicity.
BACKGROUND Amiodarone is an anti-arrthymic drug used to treat and prevent several types of dysrhythmias. This drug is known for multiple-organ toxicity. Lung toxicity occurs in about 1% to 5% of cases. A wide variety of lung manifestations have been described, from m... | Recovered | ReactionOutcome | CC BY-NC-ND | 33820905 | 19,195,308 | 2021-04-06 |
What was the outcome of reaction 'Toxicity to various agents'? | From the Heart to the Lung: A Case of Drug Toxicity.
BACKGROUND Amiodarone is an anti-arrthymic drug used to treat and prevent several types of dysrhythmias. This drug is known for multiple-organ toxicity. Lung toxicity occurs in about 1% to 5% of cases. A wide variety of lung manifestations have been described, from m... | Recovered | ReactionOutcome | CC BY-NC-ND | 33820905 | 19,195,308 | 2021-04-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anaemia'. | Vitamin D and COVID-19 in an immunocompromised patient with multiple comorbidities-A Case Report.
Routine 25-OH-Vitamin D3 measurement in COVID-19 patients could be of great importance, either for clinical course estimation or deciding on supplementation.
1 INTRODUCTION
We report mild COVID‐19 manifestation in a high‐... | FOLIC ACID, HYDROCHLOROTHIAZIDE\LOSARTAN, METFORMIN HYDROCHLORIDE, METHOTREXATE | DrugsGivenReaction | CC BY-NC-ND | 33821193 | 19,072,687 | 2021-03-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'COVID-19'. | Vitamin D and COVID-19 in an immunocompromised patient with multiple comorbidities-A Case Report.
Routine 25-OH-Vitamin D3 measurement in COVID-19 patients could be of great importance, either for clinical course estimation or deciding on supplementation.
1 INTRODUCTION
We report mild COVID‐19 manifestation in a high‐... | FOLIC ACID, HYDROCHLOROTHIAZIDE, LOSARTAN, METFORMIN HYDROCHLORIDE, METHOTREXATE | DrugsGivenReaction | CC BY-NC-ND | 33821193 | 19,092,234 | 2021-03-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Lymphopenia'. | Vitamin D and COVID-19 in an immunocompromised patient with multiple comorbidities-A Case Report.
Routine 25-OH-Vitamin D3 measurement in COVID-19 patients could be of great importance, either for clinical course estimation or deciding on supplementation.
1 INTRODUCTION
We report mild COVID‐19 manifestation in a high‐... | FOLIC ACID, HYDROCHLOROTHIAZIDE\LOSARTAN, METFORMIN HYDROCHLORIDE, METHOTREXATE | DrugsGivenReaction | CC BY-NC-ND | 33821193 | 19,072,687 | 2021-03-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Myelosuppression'. | Vitamin D and COVID-19 in an immunocompromised patient with multiple comorbidities-A Case Report.
Routine 25-OH-Vitamin D3 measurement in COVID-19 patients could be of great importance, either for clinical course estimation or deciding on supplementation.
1 INTRODUCTION
We report mild COVID‐19 manifestation in a high‐... | FOLIC ACID, HYDROCHLOROTHIAZIDE\LOSARTAN, METFORMIN HYDROCHLORIDE, METHOTREXATE | DrugsGivenReaction | CC BY-NC-ND | 33821193 | 19,072,687 | 2021-03-05 |
What is the weight of the patient? | Vitamin D and COVID-19 in an immunocompromised patient with multiple comorbidities-A Case Report.
Routine 25-OH-Vitamin D3 measurement in COVID-19 patients could be of great importance, either for clinical course estimation or deciding on supplementation.
1 INTRODUCTION
We report mild COVID‐19 manifestation in a high‐... | 99.5 kg. | Weight | CC BY-NC-ND | 33821193 | 19,092,234 | 2021-03-05 |
What was the administration route of drug 'METHOTREXATE'? | Vitamin D and COVID-19 in an immunocompromised patient with multiple comorbidities-A Case Report.
Routine 25-OH-Vitamin D3 measurement in COVID-19 patients could be of great importance, either for clinical course estimation or deciding on supplementation.
1 INTRODUCTION
We report mild COVID‐19 manifestation in a high‐... | Subcutaneous | DrugAdministrationRoute | CC BY-NC-ND | 33821193 | 19,092,234 | 2021-03-05 |
What was the dosage of drug 'HYDROCHLOROTHIAZIDE\LOSARTAN'? | Vitamin D and COVID-19 in an immunocompromised patient with multiple comorbidities-A Case Report.
Routine 25-OH-Vitamin D3 measurement in COVID-19 patients could be of great importance, either for clinical course estimation or deciding on supplementation.
1 INTRODUCTION
We report mild COVID‐19 manifestation in a high‐... | 12.5MG/50MG | DrugDosageText | CC BY-NC-ND | 33821193 | 19,072,687 | 2021-03-05 |
What was the dosage of drug 'METHOTREXATE'? | Vitamin D and COVID-19 in an immunocompromised patient with multiple comorbidities-A Case Report.
Routine 25-OH-Vitamin D3 measurement in COVID-19 patients could be of great importance, either for clinical course estimation or deciding on supplementation.
1 INTRODUCTION
We report mild COVID‐19 manifestation in a high‐... | 15 mg (milligrams). | DrugDosage | CC BY-NC-ND | 33821193 | 19,092,234 | 2021-03-05 |
What was the outcome of reaction 'Anaemia'? | Vitamin D and COVID-19 in an immunocompromised patient with multiple comorbidities-A Case Report.
Routine 25-OH-Vitamin D3 measurement in COVID-19 patients could be of great importance, either for clinical course estimation or deciding on supplementation.
1 INTRODUCTION
We report mild COVID‐19 manifestation in a high‐... | Recovered | ReactionOutcome | CC BY-NC-ND | 33821193 | 19,072,687 | 2021-03-05 |
What was the outcome of reaction 'COVID-19'? | Vitamin D and COVID-19 in an immunocompromised patient with multiple comorbidities-A Case Report.
Routine 25-OH-Vitamin D3 measurement in COVID-19 patients could be of great importance, either for clinical course estimation or deciding on supplementation.
1 INTRODUCTION
We report mild COVID‐19 manifestation in a high‐... | Recovered | ReactionOutcome | CC BY-NC-ND | 33821193 | 19,092,234 | 2021-03-05 |
What was the outcome of reaction 'Lymphopenia'? | Vitamin D and COVID-19 in an immunocompromised patient with multiple comorbidities-A Case Report.
Routine 25-OH-Vitamin D3 measurement in COVID-19 patients could be of great importance, either for clinical course estimation or deciding on supplementation.
1 INTRODUCTION
We report mild COVID‐19 manifestation in a high‐... | Recovered | ReactionOutcome | CC BY-NC-ND | 33821193 | 19,072,687 | 2021-03-05 |
What was the outcome of reaction 'Myelosuppression'? | Vitamin D and COVID-19 in an immunocompromised patient with multiple comorbidities-A Case Report.
Routine 25-OH-Vitamin D3 measurement in COVID-19 patients could be of great importance, either for clinical course estimation or deciding on supplementation.
1 INTRODUCTION
We report mild COVID‐19 manifestation in a high‐... | Recovered | ReactionOutcome | CC BY-NC-ND | 33821193 | 19,072,687 | 2021-03-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Condition aggravated'. | Efficacy and safety of therapeutic plasma exchange in stiff person syndrome.
The stiff person syndrome (SPS) is an extremely rare neurological disorder with primarily immune-mediated etiology. The cardinal symptoms are progressive, fluctuating axial/proximal limb muscle stiffness and spasms. The diagnosis is based on t... | BACLOFEN, CLONAZEPAM | DrugsGivenReaction | CC BY | 33821220 | 19,163,633 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hyperglycaemia'. | Efficacy and safety of therapeutic plasma exchange in stiff person syndrome.
The stiff person syndrome (SPS) is an extremely rare neurological disorder with primarily immune-mediated etiology. The cardinal symptoms are progressive, fluctuating axial/proximal limb muscle stiffness and spasms. The diagnosis is based on t... | BACLOFEN, CLONAZEPAM, DIAZEPAM, GABAPENTIN, LEVETIRACETAM, METHYLPREDNISOLONE | DrugsGivenReaction | CC BY | 33821220 | 19,244,637 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypotension'. | Efficacy and safety of therapeutic plasma exchange in stiff person syndrome.
The stiff person syndrome (SPS) is an extremely rare neurological disorder with primarily immune-mediated etiology. The cardinal symptoms are progressive, fluctuating axial/proximal limb muscle stiffness and spasms. The diagnosis is based on t... | BACLOFEN, CLONAZEPAM, DIAZEPAM, GABAPENTIN, LEVETIRACETAM, METHYLPREDNISOLONE | DrugsGivenReaction | CC BY | 33821220 | 19,244,637 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Muscle rigidity'. | Efficacy and safety of therapeutic plasma exchange in stiff person syndrome.
The stiff person syndrome (SPS) is an extremely rare neurological disorder with primarily immune-mediated etiology. The cardinal symptoms are progressive, fluctuating axial/proximal limb muscle stiffness and spasms. The diagnosis is based on t... | BACLOFEN, CLONAZEPAM, DIAZEPAM, GABAPENTIN, LEVETIRACETAM, METHYLPREDNISOLONE | DrugsGivenReaction | CC BY | 33821220 | 19,244,637 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Efficacy and safety of therapeutic plasma exchange in stiff person syndrome.
The stiff person syndrome (SPS) is an extremely rare neurological disorder with primarily immune-mediated etiology. The cardinal symptoms are progressive, fluctuating axial/proximal limb muscle stiffness and spasms. The diagnosis is based on t... | LEVETIRACETAM | DrugsGivenReaction | CC BY | 33821220 | 19,210,453 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Tachycardia'. | Efficacy and safety of therapeutic plasma exchange in stiff person syndrome.
The stiff person syndrome (SPS) is an extremely rare neurological disorder with primarily immune-mediated etiology. The cardinal symptoms are progressive, fluctuating axial/proximal limb muscle stiffness and spasms. The diagnosis is based on t... | BACLOFEN, CLONAZEPAM, DIAZEPAM, GABAPENTIN, LEVETIRACETAM, METHYLPREDNISOLONE | DrugsGivenReaction | CC BY | 33821220 | 19,244,637 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vertigo'. | Efficacy and safety of therapeutic plasma exchange in stiff person syndrome.
The stiff person syndrome (SPS) is an extremely rare neurological disorder with primarily immune-mediated etiology. The cardinal symptoms are progressive, fluctuating axial/proximal limb muscle stiffness and spasms. The diagnosis is based on t... | BACLOFEN, CLONAZEPAM, DIAZEPAM, GABAPENTIN, LEVETIRACETAM, METHYLPREDNISOLONE | DrugsGivenReaction | CC BY | 33821220 | 19,244,637 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Exposure during pregnancy'. | Acute leukemia in pregnancy: a single institutional experience with 21 cases at 10 years and a review of the literature.
Acute leukemia (AL) occurring in pregnancy is extremely rare, and its treatment is a clinical dilemma.
We retrospectively reviewed the medical records of our hospital from 2010 to 2019.
Twenty-... | CYCLOPHOSPHAMIDE, DAUNORUBICIN, PREDNISONE, VINCRISTINE | DrugsGivenReaction | CC BY | 33821734 | 19,459,874 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Live birth'. | Acute leukemia in pregnancy: a single institutional experience with 21 cases at 10 years and a review of the literature.
Acute leukemia (AL) occurring in pregnancy is extremely rare, and its treatment is a clinical dilemma.
We retrospectively reviewed the medical records of our hospital from 2010 to 2019.
Twenty-... | CYCLOPHOSPHAMIDE, DAUNORUBICIN, PREDNISONE, VINCRISTINE | DrugsGivenReaction | CC BY | 33821734 | 19,459,874 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonia'. | Acute leukemia in pregnancy: a single institutional experience with 21 cases at 10 years and a review of the literature.
Acute leukemia (AL) occurring in pregnancy is extremely rare, and its treatment is a clinical dilemma.
We retrospectively reviewed the medical records of our hospital from 2010 to 2019.
Twenty-... | CYCLOPHOSPHAMIDE, DAUNORUBICIN, PREDNISONE, VINCRISTINE | DrugsGivenReaction | CC BY | 33821734 | 19,459,874 | 2021-12 |
What was the outcome of reaction 'Pneumonia'? | Acute leukemia in pregnancy: a single institutional experience with 21 cases at 10 years and a review of the literature.
Acute leukemia (AL) occurring in pregnancy is extremely rare, and its treatment is a clinical dilemma.
We retrospectively reviewed the medical records of our hospital from 2010 to 2019.
Twenty-... | Fatal | ReactionOutcome | CC BY | 33821734 | 19,459,874 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Multisystem Inflammatory Syndrome in Adults after Mild SARS-CoV-2 Infection, Japan.
In Japan, a 51-year-old man had minimally symptomatic severe acute respiratory syndrome coronavirus 2 infection. Multisystem inflammatory syndrome was diagnosed ≈5 weeks later; characteristics included severe inflammation, cardiac dysfu... | AMPICILLIN SODIUM\SULBACTAM SODIUM, DOBUTAMINE HYDROCHLORIDE, NOREPINEPHRINE | DrugsGivenReaction | CC BY | 33821784 | 19,707,622 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug resistance'. | Differential methylation EPIC analysis discloses cisplatin-resistance related hypermethylation and tumor-specific heterogeneity within matched primary and metastatic testicular germ cell tumor patient tissue samples.
Testicular germ cell tumors (TGCTs) are among the most common solid malignancies in young-adult men, an... | BLEOMYCIN SULFATE, CISPLATIN, ETOPOSIDE, GEMCITABINE, IFOSFAMIDE, OXALIPLATIN, PACLITAXEL, VINBLASTINE | DrugsGivenReaction | CC BY | 33823933 | 19,380,072 | 2021-04-06 |
What was the dosage of drug 'BLEOMYCIN SULFATE'? | Differential methylation EPIC analysis discloses cisplatin-resistance related hypermethylation and tumor-specific heterogeneity within matched primary and metastatic testicular germ cell tumor patient tissue samples.
Testicular germ cell tumors (TGCTs) are among the most common solid malignancies in young-adult men, an... | AS PART OF BEP REGIMEN FOR THREE COURSES | DrugDosageText | CC BY | 33823933 | 19,380,072 | 2021-04-06 |
What was the dosage of drug 'CISPLATIN'? | Differential methylation EPIC analysis discloses cisplatin-resistance related hypermethylation and tumor-specific heterogeneity within matched primary and metastatic testicular germ cell tumor patient tissue samples.
Testicular germ cell tumors (TGCTs) are among the most common solid malignancies in young-adult men, an... | ADMINISTERED AS A PART OF BEP REGIMEN FOR 3 COURSES, AND AS PART OF VEIP FOR 4 COURSES AND TIP RE... | DrugDosageText | CC BY | 33823933 | 19,380,072 | 2021-04-06 |
What was the dosage of drug 'ETOPOSIDE'? | Differential methylation EPIC analysis discloses cisplatin-resistance related hypermethylation and tumor-specific heterogeneity within matched primary and metastatic testicular germ cell tumor patient tissue samples.
Testicular germ cell tumors (TGCTs) are among the most common solid malignancies in young-adult men, an... | AS PART OF BEP REGIMEN FOR 3 COURSES | DrugDosageText | CC BY | 33823933 | 19,380,072 | 2021-04-06 |
What was the dosage of drug 'GEMCITABINE'? | Differential methylation EPIC analysis discloses cisplatin-resistance related hypermethylation and tumor-specific heterogeneity within matched primary and metastatic testicular germ cell tumor patient tissue samples.
Testicular germ cell tumors (TGCTs) are among the most common solid malignancies in young-adult men, an... | AS PART OF GEMOX REGIMEN FOR 1 COURSE | DrugDosageText | CC BY | 33823933 | 19,380,072 | 2021-04-06 |
What was the dosage of drug 'IFOSFAMIDE'? | Differential methylation EPIC analysis discloses cisplatin-resistance related hypermethylation and tumor-specific heterogeneity within matched primary and metastatic testicular germ cell tumor patient tissue samples.
Testicular germ cell tumors (TGCTs) are among the most common solid malignancies in young-adult men, an... | AS PART OF VEIP FOR 4 COURSES AND TIP REGIMENS FOR 4 COURSES | DrugDosageText | CC BY | 33823933 | 19,380,072 | 2021-04-06 |
What was the dosage of drug 'OXALIPLATIN'? | Differential methylation EPIC analysis discloses cisplatin-resistance related hypermethylation and tumor-specific heterogeneity within matched primary and metastatic testicular germ cell tumor patient tissue samples.
Testicular germ cell tumors (TGCTs) are among the most common solid malignancies in young-adult men, an... | AS PART OF GEMOX REGIMEN FOR 1 COURSE | DrugDosageText | CC BY | 33823933 | 19,380,072 | 2021-04-06 |
What was the dosage of drug 'PACLITAXEL'? | Differential methylation EPIC analysis discloses cisplatin-resistance related hypermethylation and tumor-specific heterogeneity within matched primary and metastatic testicular germ cell tumor patient tissue samples.
Testicular germ cell tumors (TGCTs) are among the most common solid malignancies in young-adult men, an... | AS PART OF TIP REGIMEN FOR 4 COURSES | DrugDosageText | CC BY | 33823933 | 19,380,072 | 2021-04-06 |
What was the dosage of drug 'VINBLASTINE'? | Differential methylation EPIC analysis discloses cisplatin-resistance related hypermethylation and tumor-specific heterogeneity within matched primary and metastatic testicular germ cell tumor patient tissue samples.
Testicular germ cell tumors (TGCTs) are among the most common solid malignancies in young-adult men, an... | AS PART OF VEIP REGIMEN FOR 4 COURSES | DrugDosageText | CC BY | 33823933 | 19,380,072 | 2021-04-06 |
What was the outcome of reaction 'Drug resistance'? | Differential methylation EPIC analysis discloses cisplatin-resistance related hypermethylation and tumor-specific heterogeneity within matched primary and metastatic testicular germ cell tumor patient tissue samples.
Testicular germ cell tumors (TGCTs) are among the most common solid malignancies in young-adult men, an... | Fatal | ReactionOutcome | CC BY | 33823933 | 19,380,072 | 2021-04-06 |
What was the outcome of reaction 'Stevens-Johnson syndrome'? | Nevirapine-induced Stevens-Johnson syndrome in children living with HIV in South Africa.
Although adverse drug reactions resulting from the use of nevirapine (NVP) are well described in adults (estimated frequency of 6% - 10%), it has previously been considered less common in children (0.3% - 1.4%). Stock-outs of antir... | Recovering | ReactionOutcome | CC BY | 33824730 | 19,327,014 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiac arrest'. | Sudden Cardiac Arrest in a Patient With Sarcoidosis and Familial Hypercholesterolemia.
A 32-year-old Japanese man experienced out-of-hospital cardiac arrest. On arrival, computed tomography (CT) showed ground-glass opacity in the right lung. Emergency coronary angiography revealed triple vessel disease, then he underwe... | EVOLOCUMAB, ROSUVASTATIN | DrugsGivenReaction | CC BY | 33824802 | 19,153,510 | 2021-03-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pulmonary sarcoidosis'. | Sudden Cardiac Arrest in a Patient With Sarcoidosis and Familial Hypercholesterolemia.
A 32-year-old Japanese man experienced out-of-hospital cardiac arrest. On arrival, computed tomography (CT) showed ground-glass opacity in the right lung. Emergency coronary angiography revealed triple vessel disease, then he underwe... | EVOLOCUMAB, ROSUVASTATIN | DrugsGivenReaction | CC BY | 33824802 | 19,153,510 | 2021-03-02 |
What was the outcome of reaction 'Pulmonary sarcoidosis'? | Sudden Cardiac Arrest in a Patient With Sarcoidosis and Familial Hypercholesterolemia.
A 32-year-old Japanese man experienced out-of-hospital cardiac arrest. On arrival, computed tomography (CT) showed ground-glass opacity in the right lung. Emergency coronary angiography revealed triple vessel disease, then he underwe... | Recovering | ReactionOutcome | CC BY | 33824802 | 19,153,510 | 2021-03-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Small-Cell Lung Cancer Cavities: Primary or Secondary?
Although non-small-cell lung cancer occasionally presents as cavitary lesions, it is rare for small-cell lung cancer (SCLC) to present or progress in such a manner. If a cavitary lesion is seen in the setting of small-cell lung carcinoma, infectious etiologies must... | VORICONAZOLE | DrugsGivenReaction | CC BY | 33824833 | 19,178,821 | 2021-03-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'General physical health deterioration'. | Small-Cell Lung Cancer Cavities: Primary or Secondary?
Although non-small-cell lung cancer occasionally presents as cavitary lesions, it is rare for small-cell lung cancer (SCLC) to present or progress in such a manner. If a cavitary lesion is seen in the setting of small-cell lung carcinoma, infectious etiologies must... | VORICONAZOLE | DrugsGivenReaction | CC BY | 33824833 | 19,178,821 | 2021-03-04 |
What was the outcome of reaction 'Drug ineffective'? | Small-Cell Lung Cancer Cavities: Primary or Secondary?
Although non-small-cell lung cancer occasionally presents as cavitary lesions, it is rare for small-cell lung cancer (SCLC) to present or progress in such a manner. If a cavitary lesion is seen in the setting of small-cell lung carcinoma, infectious etiologies must... | Fatal | ReactionOutcome | CC BY | 33824833 | 19,178,821 | 2021-03-04 |
What was the outcome of reaction 'General physical health deterioration'? | Small-Cell Lung Cancer Cavities: Primary or Secondary?
Although non-small-cell lung cancer occasionally presents as cavitary lesions, it is rare for small-cell lung cancer (SCLC) to present or progress in such a manner. If a cavitary lesion is seen in the setting of small-cell lung carcinoma, infectious etiologies must... | Fatal | ReactionOutcome | CC BY | 33824833 | 19,178,821 | 2021-03-04 |
What was the administration route of drug 'EPOPROSTENOL'? | Autoimmune hypophysitis as a cause of adrenocorticotropic hormone deficiency in pulmonary arterial hypertension: a case report.
Severe pulmonary arterial hypertension (PAH) is generally treated with multiple PAH-specific vasodilators. If these agents are unsuccessful, additional treatment options are scarce, and the pr... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 33824940 | 19,389,941 | 2021-03 |
What was the dosage of drug 'EPOPROSTENOL'? | Autoimmune hypophysitis as a cause of adrenocorticotropic hormone deficiency in pulmonary arterial hypertension: a case report.
Severe pulmonary arterial hypertension (PAH) is generally treated with multiple PAH-specific vasodilators. If these agents are unsuccessful, additional treatment options are scarce, and the pr... | 35?62 NG/KG/MIN | DrugDosageText | CC BY-NC | 33824940 | 19,389,941 | 2021-03 |
What was the dosage of drug 'MACITENTAN'? | Autoimmune hypophysitis as a cause of adrenocorticotropic hormone deficiency in pulmonary arterial hypertension: a case report.
Severe pulmonary arterial hypertension (PAH) is generally treated with multiple PAH-specific vasodilators. If these agents are unsuccessful, additional treatment options are scarce, and the pr... | 10 mg (milligrams). | DrugDosage | CC BY-NC | 33824940 | 19,389,941 | 2021-03 |
What was the dosage of drug 'SILDENAFIL'? | Autoimmune hypophysitis as a cause of adrenocorticotropic hormone deficiency in pulmonary arterial hypertension: a case report.
Severe pulmonary arterial hypertension (PAH) is generally treated with multiple PAH-specific vasodilators. If these agents are unsuccessful, additional treatment options are scarce, and the pr... | 30?60 MG | DrugDosageText | CC BY-NC | 33824940 | 19,389,941 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease recurrence'. | Olanzapine and quetiapine in the prevention of a new mood episode in women with bipolar disorder during the postpartum period: a retrospective cohort study.
OBJECTIVE
To examine whether olanzapine and quetiapine are useful in the prevention of a new mood episode during the postpartum period.
METHODS
Data on 23 patien... | QUETIAPINE | DrugsGivenReaction | CC BY-NC | 33825764 | 20,254,189 | 2021-04-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Olanzapine and quetiapine in the prevention of a new mood episode in women with bipolar disorder during the postpartum period: a retrospective cohort study.
OBJECTIVE
To examine whether olanzapine and quetiapine are useful in the prevention of a new mood episode during the postpartum period.
METHODS
Data on 23 patien... | QUETIAPINE | DrugsGivenReaction | CC BY-NC | 33825764 | 20,254,189 | 2021-04-05 |
What was the dosage of drug 'QUETIAPINE'? | Olanzapine and quetiapine in the prevention of a new mood episode in women with bipolar disorder during the postpartum period: a retrospective cohort study.
OBJECTIVE
To examine whether olanzapine and quetiapine are useful in the prevention of a new mood episode during the postpartum period.
METHODS
Data on 23 patien... | 50-400 MG | DrugDosageText | CC BY-NC | 33825764 | 20,254,189 | 2021-04-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dyspnoea'. | Efficacy, Safety, and Immunogenicity of HLX02 Compared with Reference Trastuzumab in Patients with Recurrent or Metastatic HER2-Positive Breast Cancer: A Randomized Phase III Equivalence Trial.
BACKGROUND
HLX02 is an approved biosimilar of trastuzumab.
OBJECTIVE
This study aimed to evaluated the efficacy, safety, and... | DOCETAXEL | DrugsGivenReaction | CC BY-NC | 33826080 | 19,653,124 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonia'. | Efficacy, Safety, and Immunogenicity of HLX02 Compared with Reference Trastuzumab in Patients with Recurrent or Metastatic HER2-Positive Breast Cancer: A Randomized Phase III Equivalence Trial.
BACKGROUND
HLX02 is an approved biosimilar of trastuzumab.
OBJECTIVE
This study aimed to evaluated the efficacy, safety, and... | DOCETAXEL, TRASTUZUMAB | DrugsGivenReaction | CC BY-NC | 33826080 | 19,652,187 | 2021-05 |
What was the administration route of drug 'DOCETAXEL'? | Efficacy, Safety, and Immunogenicity of HLX02 Compared with Reference Trastuzumab in Patients with Recurrent or Metastatic HER2-Positive Breast Cancer: A Randomized Phase III Equivalence Trial.
BACKGROUND
HLX02 is an approved biosimilar of trastuzumab.
OBJECTIVE
This study aimed to evaluated the efficacy, safety, and... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 33826080 | 19,653,124 | 2021-05 |
What was the outcome of reaction 'Dyspnoea'? | Efficacy, Safety, and Immunogenicity of HLX02 Compared with Reference Trastuzumab in Patients with Recurrent or Metastatic HER2-Positive Breast Cancer: A Randomized Phase III Equivalence Trial.
BACKGROUND
HLX02 is an approved biosimilar of trastuzumab.
OBJECTIVE
This study aimed to evaluated the efficacy, safety, and... | Fatal | ReactionOutcome | CC BY-NC | 33826080 | 19,653,124 | 2021-05 |
What was the outcome of reaction 'Pneumonia'? | Efficacy, Safety, and Immunogenicity of HLX02 Compared with Reference Trastuzumab in Patients with Recurrent or Metastatic HER2-Positive Breast Cancer: A Randomized Phase III Equivalence Trial.
BACKGROUND
HLX02 is an approved biosimilar of trastuzumab.
OBJECTIVE
This study aimed to evaluated the efficacy, safety, and... | Fatal | ReactionOutcome | CC BY-NC | 33826080 | 19,652,187 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Condition aggravated'. | Improved Control of Tyrosine Kinase Inhibitor-Induced Diarrhea with a Novel Chloride Channel Modulator: A Case Report.
Despite the efficacy of tyrosine kinase inhibitors (TKIs) across multiple cancers, side effects including treatment-related diarrhea can impede a patient's ability to reach therapeutic doses or stay on... | BEVACIZUMAB, ERLOTINIB | DrugsGivenReaction | CC BY-NC | 33826111 | 19,665,646 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cough'. | Improved Control of Tyrosine Kinase Inhibitor-Induced Diarrhea with a Novel Chloride Channel Modulator: A Case Report.
Despite the efficacy of tyrosine kinase inhibitors (TKIs) across multiple cancers, side effects including treatment-related diarrhea can impede a patient's ability to reach therapeutic doses or stay on... | ATROPINE\DIPHENOXYLATE, AXITINIB, BEVACIZUMAB, CABOZANTINIB, ERLOTINIB, LOPERAMIDE, NIVOLUMAB, OPIUM | DrugsGivenReaction | CC BY-NC | 33826111 | 19,663,449 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Death'. | Improved Control of Tyrosine Kinase Inhibitor-Induced Diarrhea with a Novel Chloride Channel Modulator: A Case Report.
Despite the efficacy of tyrosine kinase inhibitors (TKIs) across multiple cancers, side effects including treatment-related diarrhea can impede a patient's ability to reach therapeutic doses or stay on... | BEVACIZUMAB, ERLOTINIB | DrugsGivenReaction | CC BY-NC | 33826111 | 19,625,382 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypertension'. | Improved Control of Tyrosine Kinase Inhibitor-Induced Diarrhea with a Novel Chloride Channel Modulator: A Case Report.
Despite the efficacy of tyrosine kinase inhibitors (TKIs) across multiple cancers, side effects including treatment-related diarrhea can impede a patient's ability to reach therapeutic doses or stay on... | ATROPINE\DIPHENOXYLATE, AXITINIB, BEVACIZUMAB, CABOZANTINIB, ERLOTINIB, LOPERAMIDE, NIVOLUMAB, OPIUM | DrugsGivenReaction | CC BY-NC | 33826111 | 19,663,449 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Malignant neoplasm progression'. | Improved Control of Tyrosine Kinase Inhibitor-Induced Diarrhea with a Novel Chloride Channel Modulator: A Case Report.
Despite the efficacy of tyrosine kinase inhibitors (TKIs) across multiple cancers, side effects including treatment-related diarrhea can impede a patient's ability to reach therapeutic doses or stay on... | CABOZANTINIB S-MALATE | DrugsGivenReaction | CC BY-NC | 33826111 | 20,424,125 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Metastatic renal cell carcinoma'. | Improved Control of Tyrosine Kinase Inhibitor-Induced Diarrhea with a Novel Chloride Channel Modulator: A Case Report.
Despite the efficacy of tyrosine kinase inhibitors (TKIs) across multiple cancers, side effects including treatment-related diarrhea can impede a patient's ability to reach therapeutic doses or stay on... | BEVACIZUMAB, ERLOTINIB | DrugsGivenReaction | CC BY-NC | 33826111 | 19,625,382 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Renal impairment'. | Improved Control of Tyrosine Kinase Inhibitor-Induced Diarrhea with a Novel Chloride Channel Modulator: A Case Report.
Despite the efficacy of tyrosine kinase inhibitors (TKIs) across multiple cancers, side effects including treatment-related diarrhea can impede a patient's ability to reach therapeutic doses or stay on... | ATROPINE\DIPHENOXYLATE, AXITINIB, BEVACIZUMAB, CABOZANTINIB, ERLOTINIB, LOPERAMIDE, NIVOLUMAB, OPIUM | DrugsGivenReaction | CC BY-NC | 33826111 | 19,663,449 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Somnolence'. | Improved Control of Tyrosine Kinase Inhibitor-Induced Diarrhea with a Novel Chloride Channel Modulator: A Case Report.
Despite the efficacy of tyrosine kinase inhibitors (TKIs) across multiple cancers, side effects including treatment-related diarrhea can impede a patient's ability to reach therapeutic doses or stay on... | ATROPINE\DIPHENOXYLATE, AXITINIB, BEVACIZUMAB, CABOZANTINIB, ERLOTINIB, LOPERAMIDE, NIVOLUMAB, OPIUM | DrugsGivenReaction | CC BY-NC | 33826111 | 19,663,449 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vomiting'. | Improved Control of Tyrosine Kinase Inhibitor-Induced Diarrhea with a Novel Chloride Channel Modulator: A Case Report.
Despite the efficacy of tyrosine kinase inhibitors (TKIs) across multiple cancers, side effects including treatment-related diarrhea can impede a patient's ability to reach therapeutic doses or stay on... | CABOZANTINIB S-MALATE | DrugsGivenReaction | CC BY-NC | 33826111 | 20,424,125 | 2021-06 |
What was the dosage of drug 'ATROPINE\DIPHENOXYLATE'? | Improved Control of Tyrosine Kinase Inhibitor-Induced Diarrhea with a Novel Chloride Channel Modulator: A Case Report.
Despite the efficacy of tyrosine kinase inhibitors (TKIs) across multiple cancers, side effects including treatment-related diarrhea can impede a patient's ability to reach therapeutic doses or stay on... | ATROPINE?DIPHENOXYLATE | DrugDosageText | CC BY-NC | 33826111 | 19,663,449 | 2021-06 |
What was the dosage of drug 'NIVOLUMAB'? | Improved Control of Tyrosine Kinase Inhibitor-Induced Diarrhea with a Novel Chloride Channel Modulator: A Case Report.
Despite the efficacy of tyrosine kinase inhibitors (TKIs) across multiple cancers, side effects including treatment-related diarrhea can impede a patient's ability to reach therapeutic doses or stay on... | 240 mg (milligrams). | DrugDosage | CC BY-NC | 33826111 | 19,663,449 | 2021-06 |
What was the dosage of drug 'OPIUM'? | Improved Control of Tyrosine Kinase Inhibitor-Induced Diarrhea with a Novel Chloride Channel Modulator: A Case Report.
Despite the efficacy of tyrosine kinase inhibitors (TKIs) across multiple cancers, side effects including treatment-related diarrhea can impede a patient's ability to reach therapeutic doses or stay on... | DOSE: UP TO 6 MG DAILY AS NEEDED; TINCTURE | DrugDosageText | CC BY-NC | 33826111 | 19,663,449 | 2021-06 |
What was the outcome of reaction 'Death'? | Improved Control of Tyrosine Kinase Inhibitor-Induced Diarrhea with a Novel Chloride Channel Modulator: A Case Report.
Despite the efficacy of tyrosine kinase inhibitors (TKIs) across multiple cancers, side effects including treatment-related diarrhea can impede a patient's ability to reach therapeutic doses or stay on... | Fatal | ReactionOutcome | CC BY-NC | 33826111 | 19,625,382 | 2021-06 |
What was the outcome of reaction 'Diarrhoea'? | Improved Control of Tyrosine Kinase Inhibitor-Induced Diarrhea with a Novel Chloride Channel Modulator: A Case Report.
Despite the efficacy of tyrosine kinase inhibitors (TKIs) across multiple cancers, side effects including treatment-related diarrhea can impede a patient's ability to reach therapeutic doses or stay on... | Not recovered | ReactionOutcome | CC BY-NC | 33826111 | 20,424,125 | 2021-06 |
What was the outcome of reaction 'Malignant neoplasm progression'? | Improved Control of Tyrosine Kinase Inhibitor-Induced Diarrhea with a Novel Chloride Channel Modulator: A Case Report.
Despite the efficacy of tyrosine kinase inhibitors (TKIs) across multiple cancers, side effects including treatment-related diarrhea can impede a patient's ability to reach therapeutic doses or stay on... | Fatal | ReactionOutcome | CC BY-NC | 33826111 | 20,424,125 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardio-respiratory arrest'. | Predictive factors of toxicity of TPF induction chemotherapy for locally advanced head and neck cancers.
BACKGROUND
The rate of toxic deaths related to induction chemotherapy in the treatment of locally advanced head and neck cancers is unacceptable and calls into question this therapeutic strategy, which is however hi... | APREPITANT, CISPLATIN, CORTICOSTEROID NOS, DOCETAXEL, FLUOROURACIL, GRANULOCYTE COLONY-STIMULATING FACTOR NOS, METHYLPREDNISOLONE, ONDANSETRON | DrugsGivenReaction | CC BY | 33827483 | 19,287,155 | 2021-04-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Death'. | Predictive factors of toxicity of TPF induction chemotherapy for locally advanced head and neck cancers.
BACKGROUND
The rate of toxic deaths related to induction chemotherapy in the treatment of locally advanced head and neck cancers is unacceptable and calls into question this therapeutic strategy, which is however hi... | APREPITANT, CISPLATIN, CORTICOSTEROID NOS, DOCETAXEL, FLUOROURACIL, GRANULOCYTE COLONY-STIMULATING FACTOR NOS, ONDANSETRON | DrugsGivenReaction | CC BY | 33827483 | 19,301,781 | 2021-04-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Lung disorder'. | Predictive factors of toxicity of TPF induction chemotherapy for locally advanced head and neck cancers.
BACKGROUND
The rate of toxic deaths related to induction chemotherapy in the treatment of locally advanced head and neck cancers is unacceptable and calls into question this therapeutic strategy, which is however hi... | APREPITANT, CISPLATIN, CORTICOSTEROID NOS, DOCETAXEL, FLUOROURACIL, GRANULOCYTE COLONY-STIMULATING FACTOR NOS, METHYLPREDNISOLONE, ONDANSETRON | DrugsGivenReaction | CC BY | 33827483 | 19,189,508 | 2021-04-07 |
What was the administration route of drug 'GRANULOCYTE COLONY-STIMULATING FACTOR NOS'? | Predictive factors of toxicity of TPF induction chemotherapy for locally advanced head and neck cancers.
BACKGROUND
The rate of toxic deaths related to induction chemotherapy in the treatment of locally advanced head and neck cancers is unacceptable and calls into question this therapeutic strategy, which is however hi... | Transdermal | DrugAdministrationRoute | CC BY | 33827483 | 19,189,508 | 2021-04-07 |
What was the dosage of drug 'GRANULOCYTE COLONY-STIMULATING FACTOR NOS'? | Predictive factors of toxicity of TPF induction chemotherapy for locally advanced head and neck cancers.
BACKGROUND
The rate of toxic deaths related to induction chemotherapy in the treatment of locally advanced head and neck cancers is unacceptable and calls into question this therapeutic strategy, which is however hi... | 50 MG, BID | DrugDosageText | CC BY | 33827483 | 19,301,781 | 2021-04-07 |
What was the outcome of reaction 'Cardio-respiratory arrest'? | Predictive factors of toxicity of TPF induction chemotherapy for locally advanced head and neck cancers.
BACKGROUND
The rate of toxic deaths related to induction chemotherapy in the treatment of locally advanced head and neck cancers is unacceptable and calls into question this therapeutic strategy, which is however hi... | Fatal | ReactionOutcome | CC BY | 33827483 | 19,287,155 | 2021-04-07 |
What was the outcome of reaction 'Colitis'? | Predictive factors of toxicity of TPF induction chemotherapy for locally advanced head and neck cancers.
BACKGROUND
The rate of toxic deaths related to induction chemotherapy in the treatment of locally advanced head and neck cancers is unacceptable and calls into question this therapeutic strategy, which is however hi... | Fatal | ReactionOutcome | CC BY | 33827483 | 19,289,310 | 2021-04-07 |
What was the outcome of reaction 'Death'? | Predictive factors of toxicity of TPF induction chemotherapy for locally advanced head and neck cancers.
BACKGROUND
The rate of toxic deaths related to induction chemotherapy in the treatment of locally advanced head and neck cancers is unacceptable and calls into question this therapeutic strategy, which is however hi... | Fatal | ReactionOutcome | CC BY | 33827483 | 19,301,781 | 2021-04-07 |
What was the outcome of reaction 'Febrile neutropenia'? | Predictive factors of toxicity of TPF induction chemotherapy for locally advanced head and neck cancers.
BACKGROUND
The rate of toxic deaths related to induction chemotherapy in the treatment of locally advanced head and neck cancers is unacceptable and calls into question this therapeutic strategy, which is however hi... | Fatal | ReactionOutcome | CC BY | 33827483 | 19,191,098 | 2021-04-07 |
What was the outcome of reaction 'Gastrointestinal perforation'? | Predictive factors of toxicity of TPF induction chemotherapy for locally advanced head and neck cancers.
BACKGROUND
The rate of toxic deaths related to induction chemotherapy in the treatment of locally advanced head and neck cancers is unacceptable and calls into question this therapeutic strategy, which is however hi... | Fatal | ReactionOutcome | CC BY | 33827483 | 19,289,310 | 2021-04-07 |
What was the outcome of reaction 'Lung disorder'? | Predictive factors of toxicity of TPF induction chemotherapy for locally advanced head and neck cancers.
BACKGROUND
The rate of toxic deaths related to induction chemotherapy in the treatment of locally advanced head and neck cancers is unacceptable and calls into question this therapeutic strategy, which is however hi... | Fatal | ReactionOutcome | CC BY | 33827483 | 19,189,508 | 2021-04-07 |
What was the outcome of reaction 'Pneumonia'? | Predictive factors of toxicity of TPF induction chemotherapy for locally advanced head and neck cancers.
BACKGROUND
The rate of toxic deaths related to induction chemotherapy in the treatment of locally advanced head and neck cancers is unacceptable and calls into question this therapeutic strategy, which is however hi... | Fatal | ReactionOutcome | CC BY | 33827483 | 19,191,098 | 2021-04-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Bacteraemia'. | Helicobacter canis bacteraemia in a rheumatoid arthritis patient treated with tofacitinib: case report and literature review.
BACKGROUND
Non-Helicobacter pylori species (NHPS) are newly emerging bacteria that naturally inhabit birds and mammals apart from humans and rarely cause diseases in humans. In recent years, a r... | ADALIMUMAB, METHOTREXATE, METHYLPREDNISOLONE, RITUXIMAB, TOFACITINIB | DrugsGivenReaction | CC BY | 33827581 | 19,574,198 | 2021-04-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Erythema'. | Helicobacter canis bacteraemia in a rheumatoid arthritis patient treated with tofacitinib: case report and literature review.
BACKGROUND
Non-Helicobacter pylori species (NHPS) are newly emerging bacteria that naturally inhabit birds and mammals apart from humans and rarely cause diseases in humans. In recent years, a r... | ADALIMUMAB, METHOTREXATE, METHYLPREDNISOLONE, RITUXIMAB, TOFACITINIB | DrugsGivenReaction | CC BY | 33827581 | 19,574,198 | 2021-04-08 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.